Author:
Zulian Francesco,Pain Clare
Publisher
Springer Nature Switzerland
Reference77 articles.
1. LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992;10(5):485–8.
2. Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, et al. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford). 2021;60(4):1651–8.
3. Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP, et al. Raynaud’s syndrome in children: systematic review and development of recommendations for assessment and monitoring. Clin Exp Rheumatol. 2016;34 Suppl 100(5):200–6.
4. Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud’s phenomenon in children: a retrospective review of 123 patients. Pediatrics. 2003;111(4 Pt 1):715–21.
5. Pavlov-Dolijanovic S, Damjanov N, Ostojic P, Susic G, Stojanovic R, Gacic D, et al. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary Raynaud phenomenon: a follow-up study of 250 patients. Pediatr Dermatol. 2006;23(5):437–42.